Future studies should expand beyond the examples provided and could consider innovative outcomes, such as the apparent changes in the gut microbiome content and colitis risk observed with diminished Pept1 activity in mice [71], as well as the risk of colitis in the absence of P-gp [72]. This evidence concerns the gene SLC15A1 and colitis.